Abbott India shares rally 4% after Q4 results, ₹475/share dividend declaration; check record date, other details

The drug firm had reported a net profit of ₹287 crore in the January-March period of the last fiscal.

Revenue from operations rose to ₹1,605 crore in the March quarter against ₹1,439 crore seen in the year-ago period, Abbott India Ltd said in a regulatory filing.

For the financial year ended March 31, 2025, the company reported a net profit of ₹1,414 crore as compared with ₹1,201 crore logged in FY24.

Revenue increased to ₹6,409 crore last fiscal from ₹5,849 crore logged in 2023-24 fiscal.

Final Dividend Update

In its filing to stock exchanges, Abbott India said its board has recommended payment of final dividend of ₹475 per equity share of ₹10 each for the financial year ended March 31, 2025, subject to approval of the shareholders at the ensuing 81st annual general meeting of the company scheduled to be held on Wednesday, August 13, 2025.

Dividend Record Date

The company said that the announced dividend, if approved by the shareholders, will be paid on or after Monday, August 18, 2025.

About Abbott India

Abbott India Ltd (Abbott India) is a subsidiary of Abbott Laboratories. The company develops, manufactures, and distributes science-based nutritional products, diagnostic tools, branded generic pharmaceuticals, and diabetes and vascular devices. Its product portfolio encompasses multi-specialty drugs, vitamins, and products for the treatment of hypothyroidism, vertigo, epilepsy, depression, and migraine.

Abbott India share price trend

Shares of Abbott India have climbed 13.5% in the past six months. So far in 2025, the stock price has rallied nearly 3%.